Literature DB >> 23916420

Late-onset Pompe disease (LOPD): correlations between respiratory muscles CT and MRI features and pulmonary function.

Michele Gaeta1, Emanuele Barca, Paolo Ruggeri, Fabio Minutoli, Carmelo Rodolico, Silvio Mazziotti, Demetrio Milardi, Olimpia Musumeci, Antonio Toscano.   

Abstract

Late onset Pompe disease (LOPD) is a rare muscle disorder often characterized, along the disease course, by severe respiratory failure. We describe herein respiratory muscles and lung abnormalities in LOPD patients using MR imaging and CT examinations correlated to pulmonary function tests. Ten LOPD patients were studied: 6 with a limb-girdle muscle weakness, 1 with myalgias, 2 with exertional dyspnoea and 1 with isolated hyperckemia. Respiratory function was measured using forced vital capacity (FVC) in both upright and supine positions, maximal inspiratory pressure (MIP), maximal expiratory pressure (MEP) and peak cough flow (PCF) tests. The involvement (atrophy) of diaphragms, abdominal respiratory muscles and intercostal muscles was ranked by CT and MRI examinations using appropriate scales. Height of lungs and band-like atelectasis presence were also recorded. Seven out of 10 patients showed a functional diaphragmatic weakness (FVC drop percentage >25%). In 8 out of 10 patients, involvement of both diaphragms and of other respiratory muscles was seen. The mean height of lungs in patients was significantly reduced when compared to a control group. Marked elevation of the diaphragms (lung height < 15 cm) was also seen in 6 patients. Multiple unilateral or bilateral band-like atelectasis were found in 4 patients. Statistically significant correlations were found between diaphragm atrophy grading, evaluated by MRI and CT, and FVC in supine position, FVC drop percentage passing from upright to supine position, PCF and MIP. Our data showed that diaphragm atrophy, often associated to reduced lung height and band-like atelectasis, can be considered the CT-MRI hallmark of respiratory insufficiency in LOPD patients. Early recognition of respiratory muscles involvement, using imaging data, could allow an early start of enzyme replacement therapy (ERT) in LOPD.
© 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Computed tomography; LOPD; Magnetic Resonance Imaging; Pompe disease; Pulmonary function; Respiratory muscles

Mesh:

Year:  2013        PMID: 23916420     DOI: 10.1016/j.ymgme.2013.06.023

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  24 in total

Review 1.  Multisystem late onset Pompe disease (LOPD): an update on clinical aspects.

Authors:  Antonio Toscano; Carmelo Rodolico; Olimpia Musumeci
Journal:  Ann Transl Med       Date:  2019-07

2.  Adapted physical activity and therapeutic exercise in late-onset Pompe disease (LOPD): a two-step rehabilitative approach.

Authors:  Giovanni Iolascon; Michele Vitacca; Elena Carraro; Carmelo Chisari; Pietro Fiore; Sonia Messina; Tiziana Mongini; Antimo Moretti; Valeria A Sansone; Antonio Toscano; Gabriele Siciliano
Journal:  Neurol Sci       Date:  2019-12-07       Impact factor: 3.307

3.  Clinical and molecular aspects of 30 patients with late-onset Pompe disease (LOPD): unusual features and response to treatment.

Authors:  Federica Montagnese; E Barca; O Musumeci; S Mondello; A Migliorato; A Ciranni; C Rodolico; P De Filippi; C Danesino; A Toscano
Journal:  J Neurol       Date:  2015-02-12       Impact factor: 4.849

Review 4.  A Multidisciplinary Perspective Addressing the Diagnostic Challenges of Late-Onset Pompe Disease in the Arabian Peninsula Region Developed From an Expert Group Meeting.

Authors:  Ali Al Shehri; Abdullah Al-Asmi; Abdullah Mohammed Al Salti; Abubaker Almadani; Ali Hassan; Ahmed K Bamaga; Edward J Cupler; Jasem Al-Hashel; Majed M Alabdali; Mohammed H Alanazy; Suzan Noori
Journal:  J Neuromuscul Dis       Date:  2022

5.  Bioimpedance Analysis as a Method to Evaluate the Proportion of Fatty and Muscle Tissues in Progressive Myopathy in Pompe Disease.

Authors:  Agnieszka Różdżyńska-Świątkowska; Elżbieta Jurkiewicz; Anna Tylki-Szymańska
Journal:  JIMD Rep       Date:  2015-08-08

6.  Whole-body muscle MRI to detect myopathies in non-extrapyramidal bent spine syndrome.

Authors:  Mickaël Ohana; Marie-Christine Durand; Catherine Marty; Jean-Philippe Lazareth; Thierry Maisonobe; Dominique Mompoint; Robert-Yves Carlier
Journal:  Skeletal Radiol       Date:  2014-05-31       Impact factor: 2.199

7.  A beta-blocker, propranolol, decreases the efficacy from enzyme replacement therapy in Pompe disease.

Authors:  Sang-Oh Han; Rand Pope; Songtao Li; Priya S Kishnani; Richard Steet; Dwight D Koeberl
Journal:  Mol Genet Metab       Date:  2015-10-03       Impact factor: 4.797

8.  Intracranial arterial abnormalities in patients with late onset Pompe disease (LOPD).

Authors:  Federica Montagnese; Francesca Granata; Olimpia Musumeci; Carmelo Rodolico; Stefania Mondello; Emanuele Barca; Maria Cucinotta; Anna Ciranni; Marcello Longo; Antonio Toscano
Journal:  J Inherit Metab Dis       Date:  2016-02-01       Impact factor: 4.982

9.  Cough Effectiveness and Pulmonary Hygiene Practices in Patients with Pompe Disease.

Authors:  Teresa Pitts; Rachel Bordelon; Alyssa Huff; Barry J Byrne; Barbara K Smith
Journal:  Lung       Date:  2018-10-25       Impact factor: 2.584

10.  Lung MRI and impairment of diaphragmatic function in Pompe disease.

Authors:  Stephan C A Wens; Pierluigi Ciet; Adria Perez-Rovira; Karla Logie; Elizabeth Salamon; Piotr Wielopolski; Marleen de Bruijne; Michelle E Kruijshaar; Harm A W M Tiddens; Pieter A van Doorn; Ans T van der Ploeg
Journal:  BMC Pulm Med       Date:  2015-05-06       Impact factor: 3.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.